NHANES III

Related by string. * : Nutrition Examination Survey NHANES . Nutrition Examination Surveys NHANES . NHANES . NHANES #-# . NHANES surveys . Nutritional Examination Survey NHANES . Nutrition Survey NHANES / iii . Iii . IIIs . IIID . IIi : Star Wars Episode III . Phase III clinical trials . Phase III trials . Phase III clinical . Guitar Hero III . Tha Carter III . pivotal Phase III * *

Related by context. All words. (Click for frequent words.) 74 NHANES 70 retrospective cohort 70 NHANES #-# 70 Nutrition Examination Survey NHANES 69 NHANES surveys 69 Nutrition Examination Surveys NHANES 69 NLSY 69 microalbumin 68 nondiabetic patients 68 CVD mortality 68 Swedish Mammography Cohort 68 serum lipid levels 68 Baseline characteristics 67 nonpregnant women 67 CARDIA 67 multiple logistic regression 67 hydroxyvitamin D levels 67 Wisconsin Sleep Cohort 67 Framingham Offspring Study 67 glycosylated hemoglobin HbA1c 67 serum leptin 67 postintervention 67 univariate analyzes 67 colorectal adenoma 67 fasting insulin 67 cTnT levels 67 Multivariate analysis 66 thyrotropin levels 66 tertiles 66 advanced adenoma 66 aged ≥ 66 CARDIA study 66 specific antigen PSA 66 dysglycemia 66 CHD mortality 66 highest tertile 66 multivariate analyzes 66 Nutrition Examination 66 serum vitamin D 65 serum selenium 65 dietary calcium intake 65 adiponectin concentrations 65 dietary questionnaires 65 Subgroup analyzes 65 Univariate analysis 65 intact parathyroid hormone 65 HIV uninfected 65 hip BMD 65 hsCRP levels 65 Insulin sensitivity 65 nonobese 65 serum GGT 65 HIV HCV coinfected 65 clinico pathological 64 Prostate Lung Colorectal 64 lowest tertile 64 logistic regression analyzes 64 serum creatinine levels 64 abdominal adiposity 64 colorectal neoplasia 64 underwent CABG 64 HbA1C levels 64 N telopeptide 64 mL/min/#.# m 2 64 CHD CVD 64 Health Initiative Observational 64 glycated hemoglobin HbA1c 64 glycated hemoglobin 64 serum calcium 64 BRFSS 64 β blockers 64 Univariate 64 longitudinal cohort study 64 Subgroup analysis 64 acrylamide intake 64 nondiabetic 64 logistic regression model 64 sociodemographic characteristics 64 carotid plaque 64 seropositivity 64 serum uric acid 64 liver transplant recipients 64 baseline serum creatinine 64 umol L 64 serum lipids 64 abnormal lipid 64 onset diabetes mellitus 64 abnormal lipid levels 64 calculated creatinine clearance 63 hydroxyvitamin D concentrations 63 prospective cohort 63 plasma folate 63 HOMA IR 63 odds ratios ORs 63 impaired glucose metabolism 63 colorectal adenomas 63 logistic regression models 63 nonfasting triglyceride levels 63 Multicenter AIDS 63 BMI ≥ 63 Health Examination Survey 63 fasting serum 63 prospective observational cohort 63 BMI waist circumference 63 #.#ng/ml 63 hemoglobin A1c HbA1c 63 CC genotype 63 Nutrition Examination Survey 63 serum concentrations 63 Netherlands Cohort Study 63 limiting generalizability 63 logistic regression analysis 63 undetectable HBV DNA 63 serum parathyroid hormone 63 serum ferritin 63 confidence intervals CIs 63 serum IGF 63 homocysteine concentrations 63 HbA 1c levels 63 sociodemographic factors 63 anthropometric measures 63 BMD measurements 63 PLCO 63 intima media thickness 63 #OHD levels 63 diastolic blood pressures 63 elevated ALT 63 posttreatment 63 Homocysteine levels 63 glomerular filtration rate 63 elevated LDL cholesterol 63 symptomatic VTE 63 definite stent thrombosis 63 mineral density 63 severe periodontitis 63 metabolic parameters 63 multivariate logistic regression 63 metabolite concentrations 63 estimated GFR 63 allele frequencies 62 tertile 62 coinfected patients 62 transferrin saturation 62 hemodialysis patients 62 multivariable adjusted 62 Nutrition Examination Surveys 62 Prehypertension 62 HER2 expression 62 relapsed MM 62 atherogenic dyslipidemia 62 REYATAZ r arm 62 elevated LDH 62 fasting glucose levels 62 glomerular filtration 62 Hb A1C 62 nonfatal MI 62 cardio respiratory fitness 62 MMSE scores 62 Replication NCS R 62 Osteoporotic Fractures 62 antibody titer 62 serum glucose 62 HbA 1c 62 urolithiasis 62 mm Hg diastolic 62 colorectal cancer incidence 62 retrospective cohort study 62 creatinine ratio 62 serum CRP 62 serum triglycerides 62 thyroid hormone levels 62 arterial thickening 62 chest radiographs 62 gallstone disease 62 estimated glomerular filtration 62 CYPHER Stent 62 PSA nadir 62 multivariable analysis 62 conditional logistic regression 62 nonfasting 62 μg dL 62 univariate 62 SLNB 62 elevated fasting glucose 62 Fasting blood glucose 62 poor metabolizers 62 systolic blood pressures 62 recurrent UTI 62 Nutritional Examination Survey 62 fasting plasma glucose FPG 62 nonfasting triglycerides 62 MMSE score 62 diverticular bleeding 62 ejection fractions 62 subclinical hyperthyroidism 62 undergone radical prostatectomy 62 telomere lengths 62 preintervention 62 preoperative PSA 62 histologically confirmed 62 tHcy concentrations 62 meta regression 62 ANCOVA 62 sociodemographic 62 #mmHg [001] 62 HGPIN 62 choline intake 62 Framingham Offspring 62 nmol l 62 GYTS 62 coronary calcification 61 bivariate analyzes 61 hemoglobin A1c levels 61 aminotransferase levels 61 fetuin 61 Young Adults CARDIA 61 MADIT CRT trial 61 mg BID dose 61 cTnT 61 adenoma recurrence 61 serum phosphate 61 hemoglobin concentrations 61 carotid IMT 61 underwent radical prostatectomy 61 glucose insulin 61 Arch Intern Med 61 Complication rates 61 Multivariate logistic regression 61 normotensive 61 triacylglycerol concentrations 61 Prostate Cancer Prevention 61 histological subtype 61 multivariate adjustment 61 Atherosclerosis Risk 61 univariate analysis 61 TT genotype 61 Postoperative complications 61 Nutrition EPIC 61 oxycodone CR 61 INTERHEART study 61 fasting triglycerides 61 ALLHAT 61 statistical significance p 61 cardiorespiratory fitness 61 glycated hemoglobin levels 61 microalbumin test 61 adiponectin levels 61 underwent bariatric surgery 61 Communities ARIC study 61 subgroup analyzes 61 triglyceride concentrations 61 folate concentrations 61 NSDUH 61 mmHg systolic 61 cystatin C 61 carotid stenosis 61 NESARC 61 Multivariate analyzes 61 serum urate levels 61 highest quintile 61 subclinical hypothyroidism 61 carotid artery intima media 61 advanced neoplasia 61 baseline HbA1c 61 recurrent venous thromboembolism 61 CIN3 61 trials RCTs 61 NYHA functional class 61 serum estradiol 61 aspartate aminotransferase AST 61 gestational diabetes mellitus 61 dietary intakes 61 ELBW infants 61 polyp recurrence 61 Lp PLA 2 61 urinary calcium 61 elevated triglyceride levels 61 Pharmacokinetic 61 alanine aminotransferase 61 serum testosterone 61 HSCT 61 SEER registry 61 Multi Ethnic Study 61 mm Hg systolic 61 longitudinal observational study 61 histologic subtype 61 fasting glucose 61 femoral neck BMD 61 nonvertebral fractures 61 Pharmacokinetic parameters 61 serum cholesterol 61 Digital Mammographic Imaging 61 nonvertebral fracture 61 urinary BPA 61 BRCA2 mutation carriers 61 nondepressed 61 serum BDNF 61 NPH insulin 61 clinicopathologic 61 civilian noninstitutionalized population 61 selenium supplementation 61 NAMCS 61 PCA3 scores 61 lipid lowering medications 61 μg L 60 dapagliflozin plus 60 HbA1C 60 underwent surgical resection 60 carotid artery thickness 60 cerebral microbleeds 60 National Epidemiologic Survey 60 HBeAg negative patients 60 serum homocysteine 60 familial clustering 60 tumor histology 60 Screening Trial 60 kg m² 60 liver biopsies 60 Triglyceride levels 60 nanograms milliliter 60 BLLs 60 advanced adenomas 60 LDL HDL 60 HBeAg 60 XIENCE V PROMUS Stent 60 seronegative 60 inhibin B 60 orofacial clefts 60 clinicopathological 60 covariate 60 beta carotene supplementation 60 Cardiorespiratory fitness 60 Dietary Modification Trial 60 baseline A1C 60 Cystatin C 60 fasting triglyceride levels 60 urate levels 60 HDL cholesterol triglycerides 60 flavonoid intake 60 Kaplan Meier analysis 60 nondiabetics 60 HBsAg 60 MetS 60 morphometric vertebral fractures 60 interobserver 60 ng dL 60 albumin excretion 60 substudy 60 intraobserver 60 total cholesterol triglycerides 60 waist circumference measurements 60 eosinophil count 60 Meta analyzes 60 Skin sterol 60 IPAH 60 plasma homocysteine levels 60 Primary endpoints 60 PASI scores 60 NSTE ACS 60 RE LY ® 60 serum cortisol 60 biochemical recurrence 60 prostate cancer CaP 60 Atherosclerosis MESA 60 NATRECOR ® 60 BMI percentiles 60 dosing cohort 60 folate vitamin B 60 elevated uric acid 60 SHBG levels 60 undergoing bariatric surgery 60 APOE genotype 60 multivariable logistic regression 60 hepatorenal syndrome 60 vertebral fracture 60 pre eclamptic 60 aminotransferase 60 endometrial thickness 60 prospectively defined 60 axillary lymph nodes 60 prevalences 60 Logistic regression 60 perimenopausal women 60 Kruskal Wallis test 60 cardiovascular mortality 60 HealthGrades analyzed 60 VADT 60 lipid lowering therapy 60 CP CPPS 60 mcg dL 60 chlamydial infection 60 albumin excretion rate 60 reinfarction 60 arterial thromboembolic events 60 ertapenem 60 irbesartan 60 serum PSA 60 LDL cholesterol concentrations 60 gastric cardia 60 adenoma 60 distal colon cancer 60 T1DM 60 STEP BD 60 recurrent VTE 60 transaminase elevations 60 serum PTH 60 papillary renal cell carcinoma 60 plasma selenium 60 elevated triglycerides 60 Fasting glucose 60 statistically significant correlations 60 retrospective observational study 60 evaluable subjects 60 perioperative mortality 60 #.#mg/dL 60 TEAEs 60 urinary oxalate 60 Cotinine 60 elevated serum creatinine 60 Atkins dieters cardiovascular 60 Hb A1c 60 prospective multicentre 60 mass indexes BMIs 60 parous 60 cotinine levels 60 fasting plasma 60 anthropometric measurements 60 antihypertensive medication 60 Epidemiologic studies 60 Study ARIC 60 deep venous thromboses 60 titrated glipizide 60 abnormal cytology 59 multivariable analyzes 59 isoflavone intake 59 lumbar spine BMD 59 shorter telomere length 59 microalbuminuria 59 biochemical relapse 59 cytologic 59 MDRD 59 spirometric 59 mmHg diastolic 59 RECORD1 59 myocardial infarctions MIs 59 GH deficiency 59 PON1 activity 59 hypogonadal 59 timepoint 59 core needle biopsies 59 digital rectal examination 59 Index CDAI 59 serum antibody 59 Poisson regression 59 mammographic density 59 lipid profiles 59 System IPSS 59 magnesium intake 59 Kaplan Meier survival 59 DAS# scores 59 serum phosphorous 59 pCR 59 oxycodone IR 59 baseline CD4 59 HIV seronegative 59 tHcy 59 gonococcal infections 59 Bonferroni correction 59 urinary excretion 59 troponin T 59 ALT flares 59 μg dl 59 microbiologically evaluable 59 mcg albinterferon alfa 2b 59 EURIDIS 59 diabetes mellitus hypertension 59 endometrial hyperplasia 59 BMI z 59 familial aggregation 59 nondemented 59 hematological parameters 59 leukocyte counts 59 parous women 59 plasma lipids 59 confidence interval #.#-#.# 59 tipranavir ritonavir 59 asymptomatic carotid stenosis 59 elevated CRP 59 Logistic regression analysis 59 posttest 59 #mg/day [001] 59 statin monotherapy 59 HBeAg seroconversion 59 multivariate Cox 59 nonrandomized 59 SGPT 59 intravenous bisphosphonates 59 CIN2 + 59 Multiple logistic regression 59 carotid intima media 59 atherothrombotic disease 59 Viral load 59 ASCUS 59 THIS STUDY 59 lipid concentrations 59 TOHP 59 systolic dysfunction 59 pharmacokinetic characteristics 59 lipid levels 59 obese postmenopausal 59 serum aminotransferase levels 59 sitosterol 59 Kaplan Meier curve 59 subtrochanteric 59 Calcium intake 59 gross hematuria 59 Endothelial function 59 HIV seroconversion 59 salivary cortisol 59 MGUS 59 Histologic 59 hypertensives 59 HORIZONS AMI trial 59 serum folate 59 subanalysis 59 ALT elevation 59 μmol L 59 hemoglobin A1C 59 postoperative mortality 59 lowest quintile 59 psychiatric comorbidities 59 seroprotection 59 Fasting plasma glucose 59 Medical Expenditure Panel 59 urine albumin 59 HCV antibody 59 hypercholesterolaemia 59 aldosterone antagonist 59 basal cell nevus syndrome 59 thyrotropin 59 mg/m2 dose 59 mIU ml 59 overt hypothyroidism 59 serum potassium 59 mean ± SEM 59 Complications Trial 59 abnormal p# biomarker 59 Crohn Disease Activity 59 prepregnancy 59 urinary albumin 59 serum lipid 59 hemodynamically significant 59 Hemoglobin A1c 59 timepoints 59 atazanavir ritonavir 59 randomized controlled trials RCTs 59 Operative mortality 59 Secondary efficacy endpoints 59 NHAMCS 59 diabetes mellitus DM 59 variance ANOVA 59 Helicobacter pylori infection 59 BMI percentile 59 μg liter 59 #q# deletion syndrome 59 genotypic resistance 59 Interview Survey 59 Eur J Endocrinol 59 lipid lowering agents 59 lifetime abstainers 59 HBeAg negative 59 symptomatic intracerebral hemorrhage 59 body fatness 59 Histopathologic 59 metaanalysis 59 atypical ductal hyperplasia 59 thrombocytopenic 59 reactogenicity 59 nontraumatic 59 HbA1c levels 59 nonobese patients 59 nmol L. 59 serologic testing 59 Am J Cardiol 59 autonomic dysfunction 59 interquartile range 59 visceral adiposity 59 FluCAM arm 59 hypercalciuria 59 tipranavir r 59 serum folate concentrations 59 multivariate regression analysis 59 eGFR 59 LDL particle 59 myocardial uptake 59 nonmelanoma skin cancer 59 protein excretion 59 renal cell carcinomas 59 venous thromboembolic disease 59 benazepril 59 attain statistical significance 59 fluvastatin 59 plasma cortisol 59 Lipid Lowering Treatment 58 lipid lowering drugs 58 CR nPR 58 DEXA scans 58 nulliparous women 58 vitamin D inadequacy 58 STRIDE PD 58 Screening Trial DMIST 58 perinatal outcomes 58 erythrocyte sedimentation rate 58 PLCO trial 58 MRSA isolates 58 plasma lipid 58 % CI #.#-#.# [003] 58 fructose intolerance 58 OGTT 58 index BMI 58 Descriptive statistics 58 Kidney Disease Outcomes 58 alanine aminotransferase ALT 58 receiving antiretroviral therapy 58 HIV RNA 58 Cochrane reviewers 58 plasma triglycerides 58 axillary lymph node 58 VaD 58 d dimer 58 triglyceride concentration 58 isoprostane 58 URTI 58 depressive symptomatology 58 Women Ischemia Syndrome 58 prospective observational 58 BCG vaccinated 58 unstable angina pectoris 58 APTIVUS r 58 SUVmax 58 singleton pregnancies 58 IDDM 58 abnormal Pap test 58 spontaneous preterm delivery 58 aminotransferase ALT 58 peak VO2 58 Coronary artery calcification 58 loop diuretics 58 serum HBV DNA 58 fructosamine 58 elevated creatinine 58 hepatitis C genotype 58 Breslow thickness 58 lignan intake 58 PRADAXA #mg 58 elevated hsCRP 58 symptom exacerbation 58 bivariate analysis 58 nonexposed 58 observational cohort 58 ATACAND 58 Observational studies 58 kcal d 58 Carotid Revascularization Endarterectomy vs. 58 parasitaemia 58 flutamide 58 histopathological 58 baseline LDH 58 dairy calcium intake 58 stone formers 58 prospective observational studies 58 serum markers 58 mIU L 58 colorectal bowel 58 euthyroid 58 Cytogenetic 58 Related Conditions NESARC 58 comparator arm 58 postoperative complication 58 Prostate specific antigen 58 troponins 58 plasma homocysteine 58 fosamprenavir 58 dietary carbohydrate 58 Rectal cancer 58 preeclamptic 58 renal biopsy 58 EDSS score 58 rs# [002] 58 semistructured interviews 58 pmol L 58 serum urate 58 fluoroquinolone resistance 58 seroconverted 58 leukocyte count 58 urinary iodine 58 posttransplant 58 ABCB1 58 LV dysfunction 58 CLA supplementation 58 DAS# CRP 58 handgrip strength 58 pT3 58 National Longitudinal Survey 58 UKPDS 58 serum cotinine levels 58 lipoprotein levels 58 echocardiographic parameters 58 malignant polyps 58 hypophosphatemia 58 intima media thickness IMT 58 creatinine levels 58 heFH 58 lipoprotein Lp 58 Non inferiority 58 HBV infections 58 SCr 58 carotid plaques 58 neurodevelopmental outcome 58 carotid bruit 58 ExTRACT TIMI 58 residual confounding 58 non fasting triglycerides 58 covariates 58 2 diabetes T2D 58 apolipoprotein B 58 hydroxy vitamin D 58 -#.# log# copies mL 58 del 5q MDS 58 elevated depressive symptoms 58 Baltimore Longitudinal Study 58 inflammatory biomarkers 58 kaempferol 58 asymptomatic PAD 58 CSF biomarkers 58 Multiethnic Study 58 subclinical atherosclerosis 58 urinary N telopeptide 58 adenotonsillectomy 58 Kaplan Meier method 58 gadobutrol 58 glycosylated hemoglobin 58 MERIT ES 58 pharyngeal cancer 58 macroalbuminuria 58 nephrolithiasis 58 Low birthweight 58 patients undergoing CABG 58 anemia hemoglobin 58 radical retropubic prostatectomy 58 adenomatous polyps 58 binary restenosis 58 LVSD 58 nonadherent 58 Cancer Epidemiol Biomarkers Prev 58 fasting lipid 58 SNP rs# [002] 58 serum triglyceride 58 mmol l 58 MDRD equation 58 Prostate Specific Antigen 58 prehypertensive 58 microg 58 aminotransferases 58 perioperative complications 58 inversely associated 58 pretransplant 58 Platelet counts 58 dietary folate intake 58 retrospectively analyzed 58 Adenomas 58 syndromal 58 #:#-# [029] 58 fetal chromosomal 58 waist girth 58 Proteinuria 58 NCT# ClinicalTrials.gov 58 UGT#A# * 58 DASH diet 58 pre pubertal 58 thromboembolic 58 antigen PSA 58 plasma leptin 58 gestational hypertension 58 chi squared 58 #OHD 58 arterial stiffening 58 comorbid depression 58 breast carcinoma 58 Dr. Sara Forhan 58 hematopoietic cancers 58 antihypertensive medications 58 neutrophil counts 58 SEER database 58 VLBW infants 58 generalized edema 58 TRITON TIMI 58 Saliva samples 58 folate supplementation 58 underwent resection 58 anti JCV antibodies 58 Kaplan Meier 58 hydroxyvitamin D 58 Folfox 58 folate intake 58 sociodemographic variables 58 antidiabetic medication 58 % CI #.#-#.# [006] 57 Response Evaluation Criteria 57 riociguat 57 rs# [001] 57 underwent liver transplantation 57 dose ionizing radiation 57 abdominal circumference 57 hemoglobin Hb 57 neurocognitive function 57 bowel polyps 57 histopathologic examination 57 placebo controlled clinical trials 57 NMIBC 57 actigraphy 57 NIH CPSI 57 NATRECOR R 57 colorectal polyp 57 lipid parameters 57 immunohistochemical 57 regression coefficients 57 transvaginal sonography 57 apo B apo AI 57 AST ALT 57 dyslipidaemia 57 #mg/dL [001] 57 plasma pharmacokinetics 57 sleeve lobectomy 57 dietary glycemic index 57 randomized multicenter trial 57 Ovarian PLCO Cancer 57 Serum creatinine 57 PREZISTA r arm 57 % Confidence Interval 57 maternal serum 57 osteosarcomas 57 thickness IMT 57 hemodilution 57 % CI #.#-#.# [008] 57 DEXA scan 57 lopinavir r arm 57 Reynolds Risk Score 57 ICDs implanted 57 -#.# ± [001] 57 recurrent metastatic 57 baseline Hb 57 COPD exacerbation 57 coronary stenosis 57 aneurysmal subarachnoid hemorrhage 57 HCV RESPOND 2 57 bivariate 57 Antihypertensive 57 rs# [004] 57 oxygen desaturation 57 rosuvastatin #mg 57 HRQL 57 HCV SPRINT 57 DMIST 57 Epidemiologic Follow 57 nodal metastases 57 Avandia Actos 57 hepatectomy 57 interobserver reliability 57 KRAS mutations occur 57 baseline FEV 57 LVNC 57 ICSI cycles 57 serum albumin 57 J Immunol 57 potential confounders 57 median survivals 57 severe rotavirus gastroenteritis 57 HIV tropism 57 urinary sodium excretion 57 beta blocker therapy 57 transient elastography 57 bronchoalveolar lavage BAL 57 noncardiovascular mortality 57 dehydroepiandrosterone sulfate 57 selenium intake 57 indexes BMIs 57 cells uL 57 calcium intakes 57 atopic sensitization 57 induced sputum 57 prospectively enrolled 57 prospectively randomized 57 hemoglobin concentration 57 psychiatric morbidity 57 efavirenz EFV 57 Canadian Multicentre Osteoporosis 57 transrectal ultrasound guided 57 P = .# 57 LV ejection fraction 57 â ‰ ¥ 57 Nonalcoholic Fatty Liver Disease 57 osteopenic 57 pairwise comparisons 57 LAGB 57 endometrial biopsy 57 Sociodemographic 57 severe hypoglycaemia 57 obstructive coronary artery 57 lipid abnormalities 57 hypovitaminosis D 57 Kidney Int 57 MACCE 57 pulmonary arterial 57 SORT OUT III 57 ug dose 57 NNRTI resistance 57 exploratory endpoints 57 microbleeds 57 thromboembolism 57 dietary intake 57 chemoprevention trials 57 Study AREDS 57 median CD4 57 strontium ranelate 57 anti HBs 57 muscle biopsies 57 pathologic diagnosis 57 ipsilateral stroke 57 CIMZIA ™ 57 syncopal 57 Taxus Stent 57 metabolic syndrome MetS 57 congenital toxoplasmosis 57 DCCT 57 NIHSS 57 suicide attempters 57 multiphasic 57 postmenopausal hormones 57 laboratory abnormalities 57 chronic periodontitis 57 nonfatal myocardial infarction MI 57 ASPS statistics 57 Stenting Trial CREST 57 % CI #.#-#.# [004] 57 TAXUS Stent 57 prepregnancy BMI 57 baseline FEV1 57 ischemic cardiomyopathy 57 immunohistochemical staining 57 μg g 57 HMGA1 57 vascular dysfunction 57 plasma adiponectin 57 PSADT 57 aspartate aminotransferase 57 sperm morphology 57 lactate dehydrogenase 57 Randomized trials 57 Nephrol Dial Transplant 57 prognostic variables 57 histologic examination 57 eculizumab therapy 57 HYVET 57 c reactive protein 57 IMPROVE HF 57 cerebral oxygenation 57 virologic failure 57 hepatic cirrhosis 57 Postoperative 57 glycemia 57 antiretroviral naïve 57 QTcF 57 fragility fracture 57 COMT genotype 57 XIENCE V demonstrated 57 hepatic enzymes 57 ANOVA 57 Nationwide Inpatient Sample 57 urodynamic 57 #:#-# [031] 57 conventional coronary angiography 57 clinically evaluable patients 57 milligrams deciliter 57 cells mcL 57 thyroglobulin 57 NNT = 57 pulmonary dysfunction 57 bezafibrate 57 nonalcoholic steatohepatitis 57 Survey MEPS 57 estrogen metabolites 57 hypokalemia 57 serum retinol 57 nonischemic 57 oral diclofenac 57 corneal thickness 57 per deciliter mg 57 NP CRNs

Back to home page